Skip to main content

Solid Biosciences Inc.

SLDB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001707502

In the last 90 days, Solid Biosciences Inc. insiders filed 0 open-market purchases and 1 sale; 157 institutions reported holding it in 13F filings for Q3 2026, worth $856.6M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 20, 2026
$697.6M
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $24.6K in total
1
13F holdersQ3 2026, +4 vs. previous quarter
157
13F valueReported value at the end of Q3 2026
$856.6M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
–
No comparable prior period
Net income, FY2025
-$174.3M
No comparable prior period
Free cash flow, FY2025
-$157.4M
No comparable prior period
Revenue, Q3 FY2026
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
13.3M
Shares sold short
Change
+1.00M
+8.2% vs. previous
Days to cover
10.71
At average daily volume

Superinvestors holding SLDB, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding SLDB at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Solid Biosciences Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 20, 2026 (view filing)4:05 PM ETOct 191 dayBrooks GabrielChief Medical OfficerSSale−4.37K$5.62−$24.6K−4.3%97.2K after10b5-1
Feb 18, 2026 (view filing)Feb 18Same dayCumbo AlexanderPresident and CEOSSale−16.6K$5.82−$96.9K−6.6%235.4K after10b5-1
Feb 18, 2026 (view filing)Feb 18Same dayHanrahan JessieChief Regulatory OfficerSSale−4.13K$5.82−$24.1K−5.3%74.3K after10b5-1
Feb 18, 2026 (view filing)Feb 18Same dayGanot IlanDirectorSSale−2.66K$5.82−$15.5K−8.8%27.5K after10b5-1
Feb 18, 2026 (view filing)Feb 18Same dayHerzich PaulChief Technology OfficerSSale−3.62K$5.82−$21.0K−4.7%72.6K after10b5-1
Feb 18, 2026 (view filing)Feb 18Same dayHowton David TChief Operating OfficerSSale−7.47K$5.82−$43.5K−6.6%105.1K after10b5-1
Feb 18, 2026 (view filing)Feb 18Same dayBrooks GabrielChief Medical OfficerSSale0–$00.0%89.5K after10b5-1
Feb 18, 2026 (view filing)Feb 18Same dayTan KevinCFO & TreasurerSSale−5.40K$5.82−$31.5K−5.2%99.4K after10b5-1
Feb 6, 2026 (view filing)Feb 42 daysHowton David TChief Operating OfficerSSale−18.9K$6.44−$121.7K−16.2%97.9K after10b5-1
Feb 6, 2026 (view filing)Feb 42 daysCumbo AlexanderPresident and CEOSSale−48.9K$6.44−$315.0K−18.1%222.0K after10b5-1

Top 10 13F holders, Q3 2026

See all 157 holders

The largest institutional positions in Solid Biosciences Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding SLDB in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Ra Capital Management, L.P.12,036,126$87.0M0.87%00.0%Unchanged
Perceptive Advisors LLC11,906,646$86.1M1.61%00.0%Unchanged
Bain Capital Life Sciences Investors, LLC9,808,819$70.9M4.76%00.0%Unchanged
Siren, L.L.C.7,690,405$55.6M1.32%00.0%Unchanged
FMR LLC7,273,369$52.6M0.00%+397,412+5.8%Added
BlackRock, Inc.6,835,244$49.4M0.00%−99,004−1.4%Reduced
RTW Investments, LP5,905,426$42.7M0.43%+2,012,500+51.7%Added
Armistice Capital, LLC4,496,000$32.5M1.09%+218,000+5.1%Added
Vanguard Capital Management LLC3,967,899$28.7M0.00%−42,023−1.0%Reduced
Franklin Resources Inc4,193,497$27.3M0.01%+752,789+21.9%Added

Holders of 5% or more of SLDB

See all 7 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Solid Biosciences Inc..

Largest holders of SLDB from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Perceptive Advisors LLC13D/A11.20%12.0M shares−1.70 ppfrom 12.90%Mar 23, 20219 filingsAug 14, 2026SEC
Ra Capital Management, L.P.13D/A10.80%12.0M shares−1.10 ppfrom 11.90%Mar 23, 202112 filingsNov 6, 2026SEC
Invus Global Management, LLC13G/A9.99%10.1M shares+0.39 ppfrom 9.60%Aug 2, 20245 filingsMay 5, 2026SEC
BCLS SB Investco, LP13D/A8.80%8.60M shares+1.00 ppfrom 7.80%Mar 25, 20219 filingsMar 10, 2026SEC
FMR LLC13G7.00%6.88M sharesNewAug 6, 20261 filingAug 6, 2026SEC